Editorial Calendar
Plan your engagement with the issues shaping healthcare evidence.
To help our partners plan ahead and engage with the topics shaping the future of healthcare evidence, The Evidence Base® publishes an Editorial Calendar outlining key themes, policy developments, and major conferences we will be covering throughout the year.
Our coverage is guided by the issues most relevant to stakeholders working across real-world evidence (RWE), health technology assessment (HTA), health economics and outcomes research (HEOR), market access, and patient-centered healthcare.
Alongside regular news and analysis, our calendar also highlights the major conferences where The Evidence Base will be reporting, interviewing experts, and publishing session insights. These moments create natural opportunities for partners to contribute perspectives through formats such as:
Webinars and Panel Discussions
If you are interested in partnering with us around a specific theme or conference, we would be pleased to discuss how we can work together to create content that informs the community while supporting your strategic objectives.
Explore our Editorial Calendar below for upcoming themes and opportunities.
2026
| January |
Theme: The Future of Global Drug Pricing: Navigating MFN, IRA, and International Reference Pricing |
| February |
Theme: Understanding MFN Pricing Models and Their Impact On Global Pricing Strategies |
| March |
Conference coverage: World Evidence, Pricing and Access Congress 2026 |
| April |
Theme: Understanding the Target Trial Framework in Evidence Generation |
| May |
Conference coverage: ISPOR 2026 Annual Meeting Theme: Beyond the Trial: Using Real-World Evidence to Demonstrate Value Across the Lifecycle |
| June |
Conference coverage: GetReal Institute Annual Conference 2026 Conference coverage: World Orphan Drug Congress USA Theme: Beyond Single-Disease Models: Rethinking Economic Modeling for Multi-Indication Therapies |
| July |
Theme: EU HTA in Action: Preparing for the Era of Joint Clinical Assessments Theme: Rare Diseases and Evidence Generation: New Approaches for Small Populations |
| August |
Conference coverage: ISPE 2026 Annual Meeting Theme: Where Are We Now? Latest US Real-World Evidence Policy Developments |
| September |
Conference coverage: ISPE Annual Meeting (coverage continues) Theme: Fit-for-Purpose Data: Ensuring Real-World Data Meets Decision-Maker Needs Theme: Registry-Enabled Pharmacovigilance: How Independent Registries Are Shaping Fit-For-Purpose Post-Authorization Safety Studies |
| October |
Conference coverage: DIA’s 2026 Real-World Evidence Conference Theme: Early Access Programs: Unlocking Opportunities for Real-World Evidence Generation Theme: HEOR in Focus: Proving Value in an Era of Increasing Scrutiny |
| November |
Conference coverage: ISPOR Europe 2026 Theme: Integrated Evidence Generation: Building Evidence Strategies to Support Regulatory and Reimbursement Decisions |
| December |
Theme: Patient-Centered Evidence: PROs, Preferences, and Patient Experience Data Theme: Looking Ahead: Policy Trends Shaping Evidence, Access, and Pricing in 2027 |
2027
Upcoming themes include:
- EU HTA in Practice: How Joint Clinical Assessments Are Shaping National Decision-Making
-
AI in Real-World Evidence: Validation, Transparency, and Decision-Maker Acceptance
-
Real-World Evidence in Oncology: External Controls, Novel Endpoints, and Evidence Gaps
-
From Data Access to Data Utility: Federated Networks, EHDS, and Cross-Border Evidence Generation
-
Pricing and Access in Transition: Global Policy, Reform, and Affordability Pressures
Download the Media Pack or get in touch to discuss opportunities aligned with our Editorial Calendar and the global conference schedule.
Please note all content published on The Evidence Base subject to approval by editorial staff for relevance, originality, timeliness and focus. Editorial features are not peer reviewed but we will work with you to edit and review any feature, where possible, prior to publication. The Evidence Base reserves the right to not publish any feature should we consider this to be outside of our editorial standards.
The views expressed in sponsored content do not necessarily reflect the views of The Evidence Base or Becaris Publishing Limited.